The basic formula Concentration (mg/mL) = Total peptide (mg) Water volume (mL) For a 70mg vial with 3mL water: 70 3 = 23.33 mg/mL Volume to draw (mL) = Desired dose (mg) Concentration (mg/mL) For 2.33mg dose at 23.33 mg/mL: 2.33 23.33 = 0.10mL = 10 units on an insulin syringe Common vial sizes and calculations 42mg vial with 1.8mL water: Concentration: 23.33 mg/mL Standard dose (2.33mg): 10 units Conservative dose (1.165mg): 5 units Vial provides approximately 18 doses at standard protocol 70mg vial with 3mL water: Concentration: 23.33 mg/mL Standard dose (2.33mg): 10 units Conservative dose (1.165mg): 5 units Vial provides approximately 30 doses at standard protocol 70mg vial with 2mL water (higher concentration): Concentration: 35 mg/mL Standard dose (2.33mg): 6.7 units (round to 7) Conservative dose (1.165mg): 3.3 units (round to 3) Smaller volumes make precise measurement more difficult The SeekPeptides peptide calculator automates these calculations for any vial size and desired dose
Consider stacking BPC-157 with: Hydrolyzed collagen and BioCell collagen raw material for connective tissue repair MSM and glucosamine joint inflammation reduction Setria glutathione and Siliphos milk thistle cellular detox and liver support Pomella pomegranate and Bergavit vascular health and recovery You can find many of these clinically validated ingredients in Swolverines recovery stack lineup
Journal of epithelial biology & pharmacology, 5 (Suppl 1-M7), 47
NICE has appraised semaglutide (Wegovy, TA875) and liraglutide (Saxenda, TA664) as licensed options for weight management in eligible adults within specialist weight management services
We track progress at follow-up visits and adjust as needed
No lethal dose identified at doses up to 20 mg/kg in animal studies No organ toxicity observed across multiple organ systems Negative mutagenicity testing across standard assays No teratogenic effects in pregnancy studies Limited long-term human data beyond 6 weeks Theoretical Considerations The primary theoretical concern relates to BPC-157s angiogenic properties
